LIGAND PHARMACEUTICALS INC ($LGND)
Filing Information
| Accession Number | 0002001011-26-000103 |
|---|---|
| Form Type | 4 |
| Filing Date | Jun 12, 2026 |
| Document | View SEC Filing |
Transactions
4
Total Shares
8,774
Total Value
$1,250,000.00
P&L
+inf% (+$955,765.50)
Transactions
| Name | Title | Security | Derivative | Transaction Date | Type | Shares | Price | Total Cost | Shares After | Direct/Indirect | Nature of Ownership | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Director | Common Stock | โ | Jun 5, 2026 | Grant/Award | 836 | $0.00 | $0.00 | 107,580 | Direct | โ | View Details | |
Director | Common Stock | โ | Jun 10, 2026 | Sale | 500 | $250.00 | $125,000.00 | 107,080 | Direct | โ | View Details | |
Director | Common Stock | โ | Jun 11, 2026 | Sale | 4,500 | $250.00 | $1,125,000.00 | 102,580 | Direct | โ | View Details | |
Director | Non-Qualified Stock Option (right to buy) | Derivative | Jun 5, 2026 | Grant/Award | 2,938 | $0.00 | $0.00 | 2,938 | Direct | โ | View Details |